The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neuropsychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11682249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of SB‐271046: A potent, selective and orally active 5‐HT6 receptor antagonist

  2000cited by this paper
• In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate

  2000cited by this paper
• 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.

  1999cited by this paper
• The role of the anterior prefrontal cortex in human cognition

  1999cited by this paper
• Investigation of stretching behaviour induced by the selective 5‐HT6 receptor antagonist, Ro 04–6790, in rats

  1999cited by this paper
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• Ionotropic Glutamate Receptor Modulation of 5-HT6 and 5-HT7 mRNA Expression in Rat Brain

  1999cited by this paper
• Hippocampal synaptic plasticity and cognition

  1999cited by this paper
• Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.

  1998cited by this paper
• Central distribution and function of 5-HT6 receptor subtype in the rat brain.

  1998cited by this paper
• Involvement of 5‐HT6 receptors in nigro‐striatal function in rodents

  1998cited by this paper
• A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction.

  1997cited by this paper
• Improved method for the measurement of glutamate and aspartate using capillary electrophoresis with laser induced fluorescence detection and its application to brain microdialysis.

  1997cited by this paper
• M1 Acetylcholine Receptor Stimulation Increases the Extracellular Concentrations of Glutamate and GABA in the Medial Prefrontal Cortex of the Rat

  1997cited by this paper
• Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system.

  1997cited by this paper
• The Cerebral Cortex and Parafascicular Thalamic Nucleus Facilitate In vivo Acetylcholine Release in the Rat Striatum through Distinct Glutamate Receptor Subtypes

  1996cited by this paper
• Quantitative RT‐PCR distribution of serotonin 5‐HT6 receptor mRNA in the central nervous system of control or 5,7‐dihydroxytryptamine‐treated rats

  1996cited by this paper
• Cognitive function in schizophrenic patients.

  1996cited by this paper
• Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.

  1995cited by this paper
• Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides.

  1995cited by this paper
• Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

  1994cited by this paper
• In vivo monitoring of glutamate in the brain by microdialysis and capillary electrophoresis with laser-induced fluorescence detection.

  1993cited by this paper
• A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

  1993cited by this paper
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

  1993cited by this paper

• Serotonin Modulation of Dorsoventral Hippocampus in Physiology and Schizophrenia

  2025cites this paper
• Advancing Care in Alzheimer’s Disease: Current Treatments and Their Impact on Quality of Life

  2025cites this paper
• Intermittent theta burst stimulation is superior to 10 Hz-repetitive transcranial magnetic stimulation in promoting episodic-like memory in healthy male rats by enhancing low γ oscillation and glutamate neuronal activities of the anterior cingulate cortex.

  2025cites this paper
• Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges

  2025cites this paper
• In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease.

  2024cites this paper
• Dorsal raphe nucleus–hippocampus serotonergic circuit underlies the depressive and cognitive impairments in 5×FAD male mice

  2024cites this paper
• 5-HT6 receptors control GABAergic transmission and CA1 pyramidal cell output of dorsal hippocampus.

  2023cites this paper
• 5-HT6 Receptors Sex-Dependently Modulate Hippocampal Synaptic Activity through GABA Inhibition

  2023cites this paper
• The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence

  2023cites this paper
• Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study

  2022cites this paper
• The role of serotonin in declarative memory: a systematic review of animal and human research.

  2022cites this paper
• Participation of hippocampal 5-HT5A, 5-HT6 and 5-HT7 serotonin receptors on the consolidation of social recognition memory.

  2022cites this paper
• Rewiring of the Serotonin System in Major Depression

  2021cites this paper
• Alterations and interactions of subcortical modulatory systems in Alzheimer's disease.

  2021cites this paper
• Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau.

  2021cites this paper
• Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence.

  2021cites this paper
• Serotonin 6 receptor modulation reduces locomotor activity in C57BL/6J mice.

  2021cites this paper
• Post-traumatic stress disorder May set the neurobiological stage for eating disorders: A focus on glutamatergic dysfunction.

  2021cites this paper
• The effect of 5-HT4 serotonin receptors in the CA3 hippocampal region on D-AP5-induced anxiolytic-like effects: isobolographic analyses.

  2020cites this paper
• The 5-HT6 Receptors in the Ventrolateral Orbital Cortex Attenuate Allodynia in a Rodent Model of Neuropathic Pain

  2020cites this paper
• Maternal separation leads to regional hippocampal microglial activation and alters the behavior in the adolescence in a sex-specific manner

  2020cites this paper
• Role of Hippocampal 5-HT6 Receptors in Glucocorticoid-Induced Enhancement of Memory Consolidation in Rats

  2020cites this paper
• Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia

  2020cites this paper
• Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

  2020cites this paper
• Beta-amyloid short- and long-term synaptic entanglement.

  2019cites this paper
• Toward a Glutamate Hypothesis of Frontotemporal Dementia

  2019cites this paper
• Se — [(2,2-Dimethyl-1,3-dioxolan-4-yl) methyl] 4-chlorobenzoselenolate reduces the nociceptive and edematogenic response by chemical noxious stimuli in mice: Implications of multi-target actions

  2019cites this paper
• Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands.

  2019cites this paper
• Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1 H-Pyrrolo[3,2- c]quinolines with Neuroprotective and Procognitive Activity.

  2019cites this paper
• A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease

  2019cites this paper
• Serotonin receptor HTR6-mediated mTORC1 signaling regulates dietary restriction–induced memory enhancement

  2019cites this paper
• The pronociceptive role of 5-HT6 receptors in ventrolateral orbital cortex in a rat formalin test model.

  2019cites this paper
• Neurotransmitter deficits from frontotemporal lobar degeneration

  2018cites this paper
• The role of 5 HT6-receptor antagonists in Alzheimer’s disease: an update

  2018cites this paper
• Precisely Timed Nicotinic Activation Drives SST Inhibition in Neocortical Circuits.

  2018cites this paper
• Activation and blockade of basolateral amygdala 5‐HT6 receptor produce anxiolytic‐like behaviors in an experimental model of Parkinson's disease

  2018cites this paper
• 5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer’s disease

  2018cites this paper
• Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885

  2018cites this paper
• Time‐dependent impact of glutamatergic modulators on the promnesiant effect of 5‐HT6R blockade on mice recognition memory

  2017cites this paper
• Development and validation of sensitive LC–MS/MS method for the quantification of SUVN‐502 and its metabolite and its application for first in human pharmacokinetic study

  2017cites this paper
• Effects of the 5‐HT6 receptor antagonist idalopirdine on extracellular levels of monoamines, glutamate and acetylcholine in the rat medial prefrontal cortex

  2017cites this paper
• The 5‐HT6 receptor antagonist idalopirdine potentiates the effects of donepezil on gamma oscillations in the frontal cortex of anesthetized and awake rats without affecting sleep‐wake architecture

  2017cites this paper
• Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

  2017cites this paper
• Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior

  2017cites this paper
• Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer’s disease

  2017cites this paper
• Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment.

  2017cites this paper
• Astrocytic transporters in Alzheimer's disease.

  2017cites this paper
• Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.

  2017cites this paper
• Potential serotonergic agents for the treatment of schizophrenia

  2016cites this paper
• Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats

  2016cites this paper
• The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus.

  2016cites this paper
• Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders

  2016cites this paper
• Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation.

  2016cites this paper
• Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status

  2016cites this paper
• Excitatory/inhibitory balance of serotonergic axon connectivity in the brain

  2016cites this paper
• Activation and blockade of prelimbic 5-HT6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson's rats.

  2016cites this paper
• Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.

  2016cites this paper
• The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment.

  2016cites this paper
• Therapeutic Potential of 5-HT6 Receptor Agonists.

  2015cites this paper
• Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer’s disease

  2015cites this paper
• Serotonergic 5-HT6 Receptor Antagonists: Heterocyclic Chemistry and Potential Therapeutic Significance.

  2015cites this paper
• Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances.

  2015cites this paper
• Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function

  2015cites this paper
• Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine.

  2015cites this paper
• Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain

  2015cites this paper
• Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease

  2015cites this paper
• Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: A double in situ hybridization study.

  2015influential citation
• The effects of dietary probiotic administration on anxiety and cognition

  2015cites this paper
• Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

  2014cites this paper
• Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative

  2014cites this paper
• Serotonergic Therapies for Cognitive Symptoms in Alzheimer’s Disease: Rationale and Current Status

  2014cites this paper
• The role of serotonin in memory: interactions with neurotransmitters and downstream signaling

  2014cites this paper
• The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia

  2014cites this paper
• Idalopirdine for Alzheimer's disease: written in the stars.

  2014cites this paper
• Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.

  2013cites this paper
• Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats

  2013cites this paper
• 5-HT6 receptors and Alzheimer's disease

  2013cites this paper
• Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis

  2013influential citation
• A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats.

  2013cites this paper
• The role of glutamatergic and GABAergic systems on serotonin- induced feeding behavior in chicken

  2013cites this paper
• Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.

  2013cites this paper
• The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.

  2013cites this paper
• Altered serotonergic neurotransmission as a main player in the pathophysiology of Alzheimer's disease : structural and ultrastructural studies in a triple transgenic mouse model of the disease

  2012influential citation
• The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats

  2012cites this paper
• 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice

  2012cites this paper
• Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.

  2012cites this paper
• Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils.

  2012cites this paper
• 5HT6 receptor antagonists: a patent update. Part 1. Sulfonyl derivatives

  2012cites this paper
• Effects of Olanzapine and Clozapine on Radial Maze Performance in Naive and MK-801-Treated Mice

  2012cites this paper
• 5‐HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms

  2012cites this paper
• Activation of α‐secretase cleavage

  2012cites this paper
• The serotonergic system in ageing and Alzheimer's disease.

  2012cites this paper
• Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer’s disease

  2012cites this paper
• Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.

  2012cites this paper
• Serotonin receptors of type 6 (5-HT6): what can we expect from them?

  2011cites this paper
• The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.

  2011cites this paper
• Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models

  2011cites this paper
• Serotonin 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice.

  2011cites this paper
• The Serotonin-6 Receptor as a Novel Therapeutic Target

  2011cites this paper
• 5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes.

  2011cites this paper